Biotech One wins the COSMETIC 360 Innovation Award 2026Read more
Flagship
EncapX®
An automated, continuous platform for liposomes and LNPs.
Start here
Not sure where to start?
Request a feasibility study on your active ingredient.
Solutions
An offer for every stage
From a first screen to an EncapX® system on your site.
Latest
Biotech One wins the COSMETIC 360 Innovation Award 2026
Industry & Process category, and the REGENERATIONS Jury's Coup de cœur, for EncapX®.
Conferences, press and company updates from the Biotech One team
An exclusive member session on 6 November, on bridging R&D formulation and industrial bioproduction for liposome and LNP manufacturing.
5 November 2026
A European network of researchers, biotech companies and industrial partners. New collaborations, and nanoencapsulation closer to clinical needs.
4 November 2026
A liposome and LNP formulation platform using supercritical CO₂, to protect fragile molecules and bridge R&D and industrial production.
26 October 2026
Exhibitor in the Start-up Zone (booth SU3). Talk by Dr Elissandro Klein on continuous scCO₂ processing for vaccine delivery.
21 October 2026 · RAI Amsterdam
Innovation Award in the Industry & Process category, and the REGENERATIONS Jury’s Coup de cœur, for EncapX®.
14 October 2026 · Carrousel du Louvre, Paris
Elissandro Klein presents a poster on the continuous production of lipid-based nanoparticles using supercritical CO₂ (EncapX®).
9 October 2026 · Basel
Fabien Balme on why next-generation therapies require next-generation encapsulation technologies, at BIOPC 2026 in Lyon.
23 September 2026 · Lyon
Elissandro Klein on the continuous production of lipid-based nanoparticles using supercritical CO₂ with EncapX®.
17 September 2026 · Berlin
A continuous millifluidic platform to encapsulate active ingredients in nanoliposomes and LNPs precisely, reproducibly and at scale.
8 July 2026
EncapX® at the 14th Antibody Industrial Symposium in Montpellier, with the antibodies, biologics and preclinical community.
3 July 2026 · Montpellier
Contributing to French biomanufacturing. EncapX® brings a continuous approach to nanoparticle, nanoliposome and LNP formulation.
26 June 2026
Continuous supercritical CO₂ fractionation of wet microalgal suspensions for selective recovery of neutral lipids, by Elissandro Klein.
26 June 2026 · Clausthal-Zellerfeld, Germany
Scalable nano-encapsulation of nanoliposomes and LNPs, and low-temperature sterilisation with no toxic solvents.
24 June 2026
Biotech One joins AFSSI Sciences de la Vie, the French association of companies partnering in preclinical research, development and health innovation.
11 June 2026
Biotech One becomes an industrial member of the Bio-based Industries Consortium, with a presentation at the BIC webinar for new members on 18 June.
Biotech One attends the Eurobiomed General Assembly, hosted at Sanofi, with the regional and national health innovation ecosystem.
Le Journal des Entreprises covers EncapX®: encapsulation of fragile molecules, better stability and shelf life, and a scalable alternative to microfluidics.
Continuous encapsulation and extraction with supercritical CO₂ for cosmetic applications, in Paris.
9 April 2026 · Paris
€1M from Région Sud Investissement and CAAP Création to deploy EncapX® and Extract-X® at industrial scale.
8 April 2026
Why encapsulating fragile molecules such as RNA is an industrial challenge, and how EncapX® goes from a patented process to a ready-to-use machine.
27 March 2026
DLS main peak at 93.3 nm, PDI 0.151, a single unimodal population. Compatibility shown with RNA-based systems and other actives.
16 February 2026
Biotech One presents clean scCO₂ technologies for encapsulation, wet biomass extraction and formulation at the Bio-based Industries Consortium event in Brussels, in 2025.
12 June 2025 · Brussels
Biotech One presents supercritical CO₂ extraction at the Raw Materials for Perfumery exhibition in Grasse, 28-29 May 2024.
3 October 2024 · Grasse
A patented continuous process fractionates microalgae with supercritical CO₂ and without a drying step, to recover compounds such as omega-3.
18 July 2024
Biotech One attends the 7th TERMIS World Congress in Seattle, 25-28 June 2024, with supercritical CO₂ for tissue engineering and sterilisation.
21 June 2024 · Seattle
Biotech One takes part in the 13th International Congress on Supercritical Fluids in Montréal, 15-18 May 2022.
15 May 2022 · Montréal
No items in this filter yet.
